Top panels illustrate mechanisms of action: atropine (2.1 mg) competitively antagonizes acetylcholine at muscarinic receptors to reverse cholinergic effects (e.g., bronchorrhea, bronchospasm, bradycardia), while pralidoxime (2PAM, 600 mg) reactivates acetylcholinesterase by cleaving the nerve agentenzyme bond prior to irreversible aging. Middle panels depict the dualchamber autoinjector design, which contains atropine and pralidoxime in separate compartments and delivers both drugs sequentially via a springloaded intramuscular mechanism from a single needle
Science Bit : A 2024 study in Metabolism tied higher magnesium intake to lower BMI and reduced insulin resistance
unopposed oestrogen carries a significant risk of endometrial hyperplasia and cancer, both of which are conditions for which obesity is also an independent risk factor
Cell culture Erythroid progenitors from SCD patients were generated with peripheral blood mononuclear cells (PBMN) followed by CD34+ cell selection (#17856, StemCell Technologies)
Mar 23, 2026 You could be overpaying by thousands of dollars a year for tirzepatide
Lemon bottles contain solutions with active ingredients like bromelain, lecithin, and riboflavin (Vitamin B2)